{"url_path":"/sec/bhc/8-k/2026-07-01/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/885590/0000885590-26-000089-index.html","accession_number":"0000885590-26-000089","cik":"0000885590","ticker":"BHC","issuer_name":"Bausch Health Companies Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/885590/0000885590-26-000089-index.html","primary_entity_key":"0000885590","primary_entity_name":"Bausch Health Companies Inc."},"word_count":89,"has_tables":true,"body_markdown":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers\n\nOn June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.\n\nMr. Goettler’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices."}